Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2025-12-29 @ 5:21 PM
Study NCT ID:
NCT04816500
Status:
UNKNOWN
Last Update Posted:
2021-03-25
First Post:
2021-03-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Remote Ischemic Conditioning on Cerebral Small Vessel Disease
Sponsor:
Capital Medical University
Organization:
Study Overview
Official Title:
Study of Efficacy and Safety of Remote Ischemic Conditioning on Cerebral Small Vessel Disease
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RIC-SVD
Brief Summary:
This trial is a randomized, controlled, single-center, double-blind trial. Cerebral small vessel disease (CSVD) patients will be recruited and randomized into RIC or control group.The protective effect of remote ischemic conditioning (RIC) on CSVD will be investigated.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: